-
admin
Posts
SABRINA STANLEY BECOMES FIRST PRO-TRAIL RUNNER TO JOIN ONLYFANS TEAM
Global digital media platform expands athlete partnerships into fast-growing sport Boulder, CO, March 10, 2025 (GLOBE NEWSWIRE) — Stanley is the first runner to join...
Triangle Pro Painting Delivers Five-Star Interior Painting Services in Raleigh, NC
Raleigh, March 10, 2025 (GLOBE NEWSWIRE) — Raleigh, North Carolina – There’s nothing quite like the power of a fresh coat of paint—it can completely...
Stereotaxis to Present at 37th Annual Roth Conference
ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today...
Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
Dr. Calias to add Operational Depth and Cell Therapy Expertise to Sernova LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) — Sernova Biotherapeutics, (TSX:...
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced...
BetterLife Announces Debt Conversions
VANCOUVER, British Columbia, March 10, 2025 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging...
Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics
– Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – –...
Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC
CHENGDU, China, March 10, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly...
GIGABYTE Elevates Immersive Content with AI and XR at SXSW 2025
Experience the Future of AI-Powered Creativity! GIGABYTE AI PCs Lead You to Explore New Frontiers TAIPEI, March 10, 2025 /PRNewswire/ — GIGABYTE, a global leader...
Mitsubishi Motors Canada Launches AI-Powered “Intelligent Companion” to Transform the 2025 Outlander Buying Experience
LONDON, ARMONK, N.Y. and MISSISSAUGA, ON, March 10, 2025 /PRNewswire/ — Mitsubishi Motor Sales of Canada announces an innovative AI-powered tool designed to transform the customer...
